Commentary: Menstruation, sleep, and visual disturbances in migraine, October 2022October 4, 2022Headache & Migraine
Real-world efficacy and safety of anti-CGRP drugs in drug-resistant chronic migraineSeptember 19, 2022Headache & Migraine
Erenumab is safe and well tolerated across age groups in chronic or episodic migraineSeptember 19, 2022Headache & Migraine
Eptinezumab reduces headache days with acute medication use in patients with chronic migraineSeptember 19, 2022Headache & Migraine
Non-aura visual disturbance tied with higher risk for chronic migraine than typical auraSeptember 19, 2022Headache & Migraine
Fremanezumab improves disability outcomes in patients with episodic and chronic migraineSeptember 19, 2022Headache & Migraine
Ubrogepant more beneficial in migraine patients with mild vs moderate or severe painSeptember 19, 2022Headache & Migraine
Migraine: Combination therapy more effective than either of manual therapies September 19, 2022Headache & Migraine
Lasmiditan effective for acute treatment of perimenstrual migraineSeptember 19, 2022Headache & Migraine
CGRP antagonists effectively reduce monthly headache days in chronic migraine with medication overuse headacheAugust 21, 2022Headache & Migraine
